Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting PR Newswire (Press Release) 2d
Nagar Vikas Yojana phase-2 road works; residents fear increased water logging The Hindu 2d Article paywall
The $13 million company teaching the immune system to hunt cancer PR Newswire (Press Release) 1d Stock Market (US) Stock Market Markets
California startup Protuoso raises $9.5m for “mix-and-match” drug platform Pharmaceutical Technology 3d Biotech Pharma
Man caught with 50 kilos of marijuana ‘for personal use’ Swiss Info 09:50 Mon, 18 May Cannabis Diabetes Health
